Share on Facebook Share on Twitter Share on Google Plus Share on Pinterest Share on Linkedin
Tampa General Hospital’s Innovations in Hepatobiliary Management Symposium
OCTOBER 4-6, 2019
THE DON CESAR

REGISTER HERE!

Tampa General Hospital is excited to announce the 2019 Innovations in Hepatobiliary Management Symposium, an engaging, informative event led by leaders in the field of hepatobiliary management. This medical conference features an agenda that will cover topics related to hepatobiliary and pancreatic disorders, as well as advanced diagnostic and treatment approaches. Attendees will learn how to identify radiologic aspects and stages of malignancies, recommend appropriate initial and secondary therapies – including recognizing when transplantation is a suitable treatment – and incorporate advanced endoscopy into patient care.

This CME course is designed for medical professionals who specialize in gastroenterology, medical oncology, radiation oncology, surgical oncology, and surgery who want learn about and integrate key advances in hepatobiliary and pancreatic cancer care into clinical practice.

Room reservations for the Innovations in Hepatobiliary Management Symposium are now available.

COURSE DIRECTORS

Amy D. Lu, M.D., MPH, MBA, F.A.C.S.
Tampa General Hospital
Advanced Organ Disease and Transplantation Institute
 
Angel E. Alsina, M.D., F.A.C.S.
Tampa General Hospital 
Director Liver Cancer Program, Tampa General Hospital 
Collaborative Professor of Surgery, University of South Florida
Morsani Collage of Medicine
 
Clifford Davis, M.D.
Assistant Professor USF School of Medicine 
Associate Program Director USF IR Residency 
 
Nyingi Kemmer, M.D., MPH, MSc
Tampa General Hospital
Medical Director, Liver Transplant Program
Professor of Medicine, University of South Florida
 

COURSE DESCRIPTION

Nationally recognized faculty present a state-of-the-art update on hepatobiliary and pancreatic disorders. The program will present:

  • Multi-disciplinary approaches to the diagnosis of gastrointestinal conditions and malignancies
  • Advanced radiologic approaches
  • Role of transplantation
  • New resectional approaches to hepatobiliary and pancreatic cancer
  • New oncologic treatments and how they are incorporated in the community and in tertiary centers

TOPICS

  • Hepatitis C Updates
  • Autoimmune Hepatitis
  • High Risk NASH
  • Living Donor Liver Transplantation
  • Hepatitis C and HIV Update in Liver Transplant
  • Advanced gastro-intestinal imaging and endoscopic approaches
  • Surgical advances of pancreatic and hepatobiliary cancers
  • Interventional Radiology Treatment Updates
  • Liver transplantation for hepatobiliary cancers
  • Sequencing of therapies for advanced pancreatic and hepatobiliary cancers

TARGET AUDIENCE

This course is intended for:
  • Primary care physicians
  • Surgeons
  • Gastroenterologists
  • Medical oncologists
  • Physician assistants
  • Nurse practitioners
  • Registered nurses
  • Oncology nurses
  • Transplant nurses
  • Clinical research personnel

LEARNING OBJECTIVES

Upon conclusion of this program, participants should be able to:
  • Recognize radiologic aspects of hepatobiliary malignancies
  • Describe staging of hepatobiliary malignancies
  • Recognize new diagnostic and therapeutic interventions with advanced endoscopy
  • Identify patients with resectable pancreatic cancer
  • Identify patients suitable for a liver transplant
  • Integrate new agents in clinical care
  • Recognize the appropriate regimens for first and second line therapy in pancreatic cancer and hepatobiliary cancer

Accredidation

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  
USF Health designates this live for a maximum of 8.75 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.